Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-12

FDA Approved: VIGABATRIN — Supplemental Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for vigabatrin filed by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)